A dermatologist exists to read the largest organ of the body — the skin — as\nboth a surface to be diagnosed and a window into what is happening beneath it.\nThe skin shows everything: the benign mole and the melanoma that will kill in\ntwo years, the rash that is an annoyance and the rash that is the first sign of a\nlethal drug reaction, the lesion of a systemic disease declaring itself on the\nforearm before the patient feels sick. The dermatologist's reason for being is\nto look — closely, with trained eyes and a dermatoscope — and to know which of\nthe hundred things on the differential is the one that must come off and go to\npathology today, and which can be reassured and watched.
\n","wordCount":125},{"heading":"Core Mission","id":"core-mission","markdown":"Recognize the lesion or eruption for what it is by pattern, decide what to biopsy\nand what to leave, and catch the skin cancer and the dangerous drug reaction\nearly enough to change the outcome — without cutting into every benign mole.","html":"Recognize the lesion or eruption for what it is by pattern, decide what to biopsy\nand what to leave, and catch the skin cancer and the dangerous drug reaction\nearly enough to change the outcome — without cutting into every benign mole.
\n","wordCount":41},{"heading":"Primary Responsibilities","id":"primary-responsibilities","markdown":"The visible work is looking at skin; the actual work is pattern recognition under\nthe constant threat of the missed melanoma. A dermatologist takes a focused\nhistory (onset, evolution, symptoms, drugs, sun exposure, family history),\nexamines the whole skin surface including the scalp, nails, and mucosa, applies\ndermoscopy to magnify and structure the diagnosis, and decides whether a lesion\nneeds biopsy, excision, monitoring, or nothing. They classify and treat\ninflammatory disease — psoriasis, eczema, acne, the autoimmune blistering\ndisorders — often for years. They perform skin surgery, including Mohs for\nhigh-risk cancers, and read their own and the pathologist's slides in\nclinicopathologic correlation. Underneath it all is morphology: the precise\ndescription of what a lesion looks like, because the name follows the description.","html":"The visible work is looking at skin; the actual work is pattern recognition under\nthe constant threat of the missed melanoma. A dermatologist takes a focused\nhistory (onset, evolution, symptoms, drugs, sun exposure, family history),\nexamines the whole skin surface including the scalp, nails, and mucosa, applies\ndermoscopy to magnify and structure the diagnosis, and decides whether a lesion\nneeds biopsy, excision, monitoring, or nothing. They classify and treat\ninflammatory disease — psoriasis, eczema, acne, the autoimmune blistering\ndisorders — often for years. They perform skin surgery, including Mohs for\nhigh-risk cancers, and read their own and the pathologist's slides in\nclinicopathologic correlation. Underneath it all is morphology: the precise\ndescription of what a lesion looks like, because the name follows the description.
\n","wordCount":122},{"heading":"Guiding Principles","id":"guiding-principles","markdown":"- **Describe before you diagnose.** The morphology — macule, papule, plaque,\n vesicle, distribution, color, border — is the data. Name the lesion in the\n language of dermatology and the differential narrows itself.\n- **The dangerous diagnosis sets the threshold.** Most lesions are benign, but\n the cost of missing one melanoma is a life. The whole discipline of biopsy\n thresholds is built around that asymmetry.\n- **Pattern recognition is fast; the discipline is the lesion that breaks the\n pattern.** The \"ugly duckling\" mole that looks different from all the patient's\n others is more suspicious than any single ABCDE feature.\n- **Dermoscopy turns guessing into reading.** The naked eye sees a brown spot;\n the dermatoscope sees pigment networks, streaks, and blue-white veils that\n separate nevus from melanoma.\n- **A rash plus fever, mucosal involvement, or skin pain is an emergency until\n excluded.** SJS/TEN, DRESS, and necrotizing infection hide among benign\n eruptions and kill fast.\n- **Treat the disease over time, not the flare in the room.** Psoriasis and\n eczema are chronic; the plan is a long-term regimen, not a one-visit cream.","html":"Dermatology is tightly coupled to pathology — so tightly that many dermatologists\nread their own slides, and the dermatopathologist is the partner who confirms the\ndiagnosis behind the diagnosis. Clinicopathologic correlation is a two-way\nconversation, not a one-way report. The dermatologist works with the plastic\nsurgeon and head-and-neck surgeon for large reconstructions after cancer\nexcision, the medical oncologist for advanced melanoma now treated with\nimmunotherapy, the rheumatologist for the cutaneous signs of systemic autoimmune\ndisease, and the primary care physician who refers the lesion and manages the\npatient's other illness. The recurring friction is the referral label: the\ndiscipline is to re-examine and re-describe rather than inherit a prior diagnosis.
\n","wordCount":115},{"heading":"Ethics","id":"ethics","markdown":"Dermatology straddles medical necessity and cosmetic demand, and the line is\nwhere the ethics live. The honest dermatologist biopsies what needs biopsying and\ndeclines to sell cosmetic procedures dressed up as medical ones. The asymmetry of\nmelanoma justifies vigilance, but over-biopsy and overdiagnosis of indolent\nlesions cause real harm — scars, anxiety, and cost — and the patient deserves an\nhonest account of the trade. Access matters: skin cancer is curable when caught\nearly, and the patient who can't get a timely skin check is the one who presents\nwith a thick melanoma. Diagnoses in skin of color are missed when the training\nimages were all on light skin; the duty is to know the patterns across all\npatients. And reassurance must be honest — never falsely calm a changing lesion to\nend the visit faster.","html":"Dermatology straddles medical necessity and cosmetic demand, and the line is\nwhere the ethics live. The honest dermatologist biopsies what needs biopsying and\ndeclines to sell cosmetic procedures dressed up as medical ones. The asymmetry of\nmelanoma justifies vigilance, but over-biopsy and overdiagnosis of indolent\nlesions cause real harm — scars, anxiety, and cost — and the patient deserves an\nhonest account of the trade. Access matters: skin cancer is curable when caught\nearly, and the patient who can't get a timely skin check is the one who presents\nwith a thick melanoma. Diagnoses in skin of color are missed when the training\nimages were all on light skin; the duty is to know the patterns across all\npatients. And reassurance must be honest — never falsely calm a changing lesion to\nend the visit faster.
\n","wordCount":134},{"heading":"Scenarios","id":"scenarios","markdown":"**The \"stable old mole\" the patient mentions in passing.** A 50-year-old comes in\nfor acne and offhandedly says a back mole has been there for years. On full-skin\nexam it's the ugly duckling — darker and more irregular than his dozen other\nnevi. Dermoscopy shows an atypical pigment network with focal blue-white veil.\nABCDE is only borderline, but the ugly-duckling sign and the dermoscopic\nstructures override the reassuring history. The expert performs an excisional\nbiopsy with narrow margins — not a shave — preserving Breslow depth. Pathology:\nmelanoma in situ. The discipline that caught it was examining the skin he didn't\ncome in for and trusting structure over story.\n\n**The morbilliform rash on day 10 of an antibiotic.** A patient develops a\nwidespread red rash a week and a half into amoxicillin. Most are benign drug\neruptions. The expert checks the red flags: facial edema, fever to 38.8, tender\nskin, and a lab shows eosinophilia with a rising ALT. This is DRESS, not a simple\nexanthem. The decision is to stop the drug immediately, admit, monitor organ\nfunction, and start systemic steroids — treating it as the potentially fatal\nreaction it is rather than reassuring and continuing.\n\n**The chronic \"eczema\" that won't clear.** A 60-year-old has had an itchy,\nscaly, patchy eruption for two years, called eczema and treated with steroids\nthat never quite work. The expert resists the inherited label, notes the patches\nare well-demarcated and somewhat atrophic in sun-protected sites, and biopsies\nrather than re-prescribing. Histology shows an atypical lymphocytic infiltrate:\nearly mycosis fungoides (cutaneous T-cell lymphoma). Refusing to keep calling an\nunexplained chronic rash \"eczema\" changed the diagnosis and the patient's path.","html":"The "stable old mole" the patient mentions in passing. A 50-year-old comes in\nfor acne and offhandedly says a back mole has been there for years. On full-skin\nexam it's the ugly duckling — darker and more irregular than his dozen other\nnevi. Dermoscopy shows an atypical pigment network with focal blue-white veil.\nABCDE is only borderline, but the ugly-duckling sign and the dermoscopic\nstructures override the reassuring history. The expert performs an excisional\nbiopsy with narrow margins — not a shave — preserving Breslow depth. Pathology:\nmelanoma in situ. The discipline that caught it was examining the skin he didn't\ncome in for and trusting structure over story.
\nThe morbilliform rash on day 10 of an antibiotic. A patient develops a\nwidespread red rash a week and a half into amoxicillin. Most are benign drug\neruptions. The expert checks the red flags: facial edema, fever to 38.8, tender\nskin, and a lab shows eosinophilia with a rising ALT. This is DRESS, not a simple\nexanthem. The decision is to stop the drug immediately, admit, monitor organ\nfunction, and start systemic steroids — treating it as the potentially fatal\nreaction it is rather than reassuring and continuing.
\nThe chronic "eczema" that won't clear. A 60-year-old has had an itchy,\nscaly, patchy eruption for two years, called eczema and treated with steroids\nthat never quite work. The expert resists the inherited label, notes the patches\nare well-demarcated and somewhat atrophic in sun-protected sites, and biopsies\nrather than re-prescribing. Histology shows an atypical lymphocytic infiltrate:\nearly mycosis fungoides (cutaneous T-cell lymphoma). Refusing to keep calling an\nunexplained chronic rash "eczema" changed the diagnosis and the patient's path.
\n","wordCount":283},{"heading":"Related Occupations","id":"related-occupations","markdown":"A dermatologist is a physician who specialized in skin, so internal medicine and\nthe diagnostic discipline of the physician are the foundation. The pathologist —\nspecifically the dermatopathologist — is the indispensable partner who confirms\nthe tissue diagnosis, making clinicopathologic correlation a daily conversation.\nThe medical oncologist now co-manages advanced melanoma with immunotherapy. The\nsurgeon and plastic surgeon reconstruct large defects after cancer excision.\nRadiologic technologists and radiologists stage deeper or metastatic disease. The\nregistered nurse runs the skin-cancer surveillance clinic and the biologic\ninfusion program.","html":"A dermatologist is a physician who specialized in skin, so internal medicine and\nthe diagnostic discipline of the physician are the foundation. The pathologist —\nspecifically the dermatopathologist — is the indispensable partner who confirms\nthe tissue diagnosis, making clinicopathologic correlation a daily conversation.\nThe medical oncologist now co-manages advanced melanoma with immunotherapy. The\nsurgeon and plastic surgeon reconstruct large defects after cancer excision.\nRadiologic technologists and radiologists stage deeper or metastatic disease. The\nregistered nurse runs the skin-cancer surveillance clinic and the biologic\ninfusion program.
\n","wordCount":86},{"heading":"References","id":"references","markdown":"- *Fitzpatrick's Dermatology in General Medicine*\n- *Dermatology* — Bolognia, Schaffer & Cerroni\n- *Andrews' Diseases of the Skin*\n- *Dermoscopy: The Essentials* — Soyer, Argenziano, et al.\n- AAD Clinical Guidelines","html":"